Mirae Asset Global Investments’s China Biologic Products Holdings, Inc. CBPO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-48,615
| Closed | -$5.76M | – | 1767 |
|
|
2021
Q1 | $5.76M | Buy |
48,615
+9,544
| +24% | +$1.13M | 0.02% | 704 |
|
|
2020
Q4 | $4.61M | Buy |
39,071
+2,215
| +6% | +$257K | 0.02% | 671 |
|
|
2020
Q3 | $4.1M | Sell |
36,856
-9,741
| -21% | -$1.05M | 0.02% | 591 |
|
|
2020
Q2 | $4.76M | Buy |
46,597
+602
| +1% | +$64.4K | 0.03% | 515 |
|
|
2020
Q1 | $4.96M | Sell |
45,995
-20,215
| -31% | -$2.32M | 0.04% | 439 |
|
|
2019
Q4 | $7.71M | Sell |
66,210
-1,931
| -3% | -$224K | 0.05% | 413 |
|
|
2019
Q3 | $7.8M | Buy |
+68,141
| New | +$6.77M | 0.05% | 377 |
|
|
2017
Q3 | – | Sell |
-124,510
| Closed | -$14.1M | – | 705 |
|
|
2017
Q2 | $14.1M | Sell |
124,510
-183,772
| -60% | -$20.5M | 0.24% | 76 |
|
|
2017
Q1 | $30.9M | Sell |
308,282
-71,494
| -19% | -$7.64M | 0.58% | 38 |
|
|
2016
Q4 | $40.8M | Sell |
379,776
-58,598
| -13% | -$6.85M | 0.91% | 24 |
|
|
2016
Q3 | $54.6M | Buy |
438,374
+40,481
| +10% | +$4.78M | 1.13% | 21 |
|
|
2016
Q2 | $42.3M | Buy |
397,893
+340,304
| +591% | +$39.5M | 1.09% | 21 |
|
|
2016
Q1 | $6.59M | Buy |
57,589
+48,977
| +569% | +$5.75M | 0.18% | 100 |
|
|
2015
Q4 | $1.23M | Buy |
+8,612
| New | +$994K | 0.04% | 298 |
|
Mirae Asset Global Investments's CBPO Position: Q2 2021 in Review
Mirae Asset Global Investments sold out of China Biologic Products Holdings, Inc. (CBPO) in Q2 2021, closing a stake of 48,615 shares — an estimated $5.76M sold.
Mirae Asset Global Investments first reported a position in CBPO in Q4 2015 and held it in 14 quarters. The position peaked at $54.6M in Q3 2016. 0 funds tracked by Wall St. Rank hold CBPO as of Q2 2021.
- Mirae Asset Global Investments reported no remaining China Biologic Products Holdings, Inc. position as of Q2 2021 after selling out during the quarter.
- Mirae Asset Global Investments sold 48,615 China Biologic Products Holdings, Inc. shares in Q2 2021, an estimated $5.76M.
- Mirae Asset Global Investments first reported a position in China Biologic Products Holdings, Inc. in Q4 2015 and held it in 14 quarters.
- Mirae Asset Global Investments's China Biologic Products Holdings, Inc. position peaked at $54.6M in Q3 2016.
- 0 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q2 2021.
Based on Mirae Asset Global Investments's 13F filing for Q2 2021, filed 11 Aug 2021.